Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.

@article{Zhou2008ExpressionOL,
  title={Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.},
  author={Li Zhou and Xiao-dong He and Quan-cai Cui and Wei-xun Zhou and Qiang Qu and Rou-li Zhou and Jing-an Rui and Jianchun Yu},
  journal={Cancer letters},
  year={2008},
  volume={264 2},
  pages={209-17}
}
LAPTM4B was proven to overexpress in hepatocellular carcinoma and relate to differentiation. We immunohistochemically investigated the expression and potential clinicopathological and prognostic significance of LAPTM4B encoded protein, LAPTM4B-35, in extrahepatic cholangiocarcinoma (EHCC) for specimens from consecutive 81 patients. LAPTM4B-35 staining was positive in cancer tissues from 59 patients (72.8%), including 12 with score 1, 22 with score 2 and 25 with score 3. No positive staining was… CONTINUE READING
33 Citations
40 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 40 references

J

  • L. Zhou, X. D. He
  • Chen, et al., Overexpression of LAPTM4B-35…
  • 2007
Highly Influential
8 Excerpts

A

  • S. Miwa, S. Miyagawa
  • Kobayashi, et al., Predictive factors for…
  • 2006
1 Excerpt

M

  • S. Tamada, H. Shibahara
  • Higashi, et al., MUC4 is a novel prognostic…
  • 2006

N

  • M. Abdel Wahab, O. Fathy
  • Elghwalby, et al., Resectability and prognostic…
  • 2006
1 Excerpt

Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery

  • S. Miyagawa, A. Kobayashi
  • J . Gastroenterol .
  • 2006

Similar Papers

Loading similar papers…